Centre for Probe Development and Commercialization

About:

CPDC engages in the development, distribution, and commercialization of molecular imaging probes and targeted radiotherapeutics.

Website: https://www.imagingprobes.ca/

Top Investors: Government of Canada

Description:

CPDC specializes in radiopharmaceutical research and development. They develop imaging agents and targeted radiotherapeutics for the detection and treatment of human diseases. Their programs in the clinical, preclinical, and discovery stages target PSMA in prostate cancer and monitor immune responses, as well as various other cancer and neurology targets.